File:Study Participant Receives Experimental Ebola Treatment mAb114 (40673902210).jpg

From Wikimedia Commons, the free media repository
Jump to navigation Jump to search

Original file ‎(3,024 × 4,032 pixels, file size: 1.74 MB, MIME type: image/jpeg)

Captions

Captions

Add a one-line explanation of what this file represents

Summary

[edit]
Description May 21, 2018 – A healthy volunteer receives an intravenous infusion of mAb114—an experimental treatment for Ebola virus disease—in a Phase 1 clinical trial held at the NIH Clinical Center in Bethesda, Maryland. Credit: NIAID
Date
Source Study Participant Receives Experimental Ebola Treatment mAb114
Author NIAID

Licensing

[edit]
w:en:Creative Commons
attribution
This file is licensed under the Creative Commons Attribution 2.0 Generic license.
You are free:
  • to share – to copy, distribute and transmit the work
  • to remix – to adapt the work
Under the following conditions:
  • attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
This image was originally posted to Flickr by NIAID at https://flickr.com/photos/54591706@N02/40673902210 (archive). It was reviewed on 10 October 2019 by FlickreviewR 2 and was confirmed to be licensed under the terms of the cc-by-2.0.

10 October 2019

File history

Click on a date/time to view the file as it appeared at that time.

Date/TimeThumbnailDimensionsUserComment
current16:19, 10 October 2019Thumbnail for version as of 16:19, 10 October 20193,024 × 4,032 (1.74 MB)Netha Hussain (talk | contribs)Transferred from Flickr via #flickr2commons

You cannot overwrite this file.

The following page uses this file:

Retrieved from "https://commons.wikimedia.org/w/index.php?title=File:Study_Participant_Receives_Experimental_Ebola_Treatment_mAb114_(40673902210).jpg&oldid=878406844"